Regeneron Pharmaceuticals Inc (REGN)

Financial leverage ratio

Dec 31, 2023 Sep 30, 2023 Jun 30, 2023 Mar 31, 2023 Dec 31, 2022 Sep 30, 2022 Jun 30, 2022 Mar 31, 2022 Dec 31, 2021 Sep 30, 2021 Jun 30, 2021 Mar 31, 2021 Dec 31, 2020 Sep 30, 2020 Jun 30, 2020 Mar 31, 2020 Dec 31, 2019 Sep 30, 2019 Jun 30, 2019 Mar 31, 2019
Total assets US$ in thousands 33,080,200 32,163,300 30,657,500 30,059,900 29,214,500 27,677,800 27,205,800 26,348,700 25,434,800 23,671,500 21,485,900 17,772,200 17,163,300 16,084,000 14,428,700 15,757,500 14,805,200 13,939,300 13,173,600 12,854,800
Total stockholders’ equity US$ in thousands 25,973,100 24,904,400 24,017,900 23,495,200 22,664,000 21,438,800 20,687,800 19,914,700 18,768,800 17,258,000 15,127,300 11,977,000 11,025,300 10,125,500 9,057,400 12,133,000 11,089,700 10,504,400 9,755,900 9,444,700
Financial leverage ratio 1.27 1.29 1.28 1.28 1.29 1.29 1.32 1.32 1.36 1.37 1.42 1.48 1.56 1.59 1.59 1.30 1.34 1.33 1.35 1.36

December 31, 2023 calculation

Financial leverage ratio = Total assets ÷ Total stockholders’ equity
= $33,080,200K ÷ $25,973,100K
= 1.27

Regeneron Pharmaceuticals, Inc.'s financial leverage ratio has remained relatively stable over the past eight quarters, fluctuating between 1.27 and 1.32. The financial leverage ratio measures the extent to which a company utilizes debt to finance its operations and growth. A ratio above 1 indicates that the company has more debt than equity in its capital structure.

Regeneron's financial leverage ratio of around 1.28 to 1.32 suggests that the company relies moderately on debt financing to support its business activities. The consistency in the ratio over the quarters indicates a balanced approach to leveraging, neither excessively relying on debt nor being overly conservative.

Staying within this range of financial leverage ratios can be considered favorable as it signifies that Regeneron has a relatively stable capital structure with a manageable level of debt. However, it is essential for the company to monitor and manage its debt levels effectively to ensure long-term financial health and sustainability.


Peer comparison

Dec 31, 2023


See also:

Regeneron Pharmaceuticals Inc Financial Leverage (Quarterly Data)